The two countries are planning precision strikes against U.S. exports in response to Trump’s unilateral tariffs.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...
We praise Rana S Hinman and colleagues 1 for their comprehensive investigation into the efficacy of telerehabilitation consultations versus in-person consultations for chronic knee pain management.
It can lead to serious foot issues like bunions, hammertoes, and ingrown toenails. High heels can also cause pain in the lower back, knees, and feet because they change how weight is distributed.